Market Cap 5.51B
Revenue (ttm) 0.00
Net Income (ttm) -183.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.04
Volume 1,803,200
Avg Vol 3,148,542
Day's Range N/A - N/A
Shares Out 134.37M
Stochastic %K 2%
Beta 2.23
Analysts Strong Sell
Price Target $66.76

Company Profile

Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Me...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 220 6633
Address:
One World Trade Center, Suite 8500, New York, United States
Suga_shaun
Suga_shaun Aug. 31 at 2:59 AM
0 · Reply
AtomicBanana
AtomicBanana Aug. 29 at 5:47 PM
$DFTX I was waiting at the pharmacy when an adult woman next to me was sobbing on the phone to her senior mother about how the withdrawals for her benzodiazepines were so bad. I could only sympathize with her as she apologized to me for her outburst but I couldn’t blame her one bit Just another reason how important it is that DT120 succeeds. Some people are talking about how Voyage only showed a 14% remission rate. Keep in mind, the trials that benzodiazepines had did not have true remission rates in their studies. The benzodiazepines trials had symptom reduction; not the HAM-A<7 remission endpoint at Week 12 that $DFTX reported I’ve taken both of these drugs before and I can tell you for a fact that I felt nothing but dirty on benzodiazepines and on street LSD I had felt cleansed for months The opportunity ahead is immense. We have an administration in support of these drugs passing. We have a mental crisis that is out of control. A huge drug addiction problem. $DFTX is the cure
1 · Reply
UncleJudd
UncleJudd Aug. 29 at 3:58 PM
$DFTX $CMPS This is tremendous
0 · Reply
Manny559
Manny559 Aug. 29 at 3:26 AM
$DFTX regarding the modest 14% remission in voyage, the only thing that I can point to is that when compared to placebo it’s significantly better than what is currently available
1 · Reply
twiggs462
twiggs462 Aug. 28 at 11:08 PM
Psychedelics Get Federal Attention @TheDalesReport https://www.youtube.com/live/10cdaXsPXcA?si=zh2kyqSlKRYOknXX&t=955 $DFTX $CMPS
1 · Reply
directorwalsh
directorwalsh Aug. 28 at 8:59 PM
$DFTX Remain quite bullish here but any thoughts on only 14% remission in Voyage? Pretty low for my expectations. Understand it’s one dose and remission is a high bar given baseline scores, but even part B seems a bit low.
0 · Reply
Nauticophil
Nauticophil Aug. 28 at 7:43 PM
$DFTX probably related to the uncertain interest rate outlook after Warsh’s Jackson Hole speech. Risk-on assets are down across the board.
0 · Reply
twiggs462
twiggs462 Aug. 28 at 7:12 PM
FDA does not require a drugs to be risk-free. It requires a favorable benefit-risk profile supported by evidence. If $CMPS & $DFTX can demonstrate robust efficacy, safety and workable monitoring, there is nothing disqualifying about psilocybin or LSD being controlled substances.
0 · Reply
AtomicBanana
AtomicBanana Aug. 28 at 6:42 PM
$DFTX Big sell day on no news so no need to ponder or react. We’re chillen
0 · Reply
Horseman23
Horseman23 Aug. 28 at 5:54 PM
$DFTX hope everyone is buying this gift of a dip
0 · Reply
Latest News on DFTX
Definium Therapeutics initiated with a Buy at BofA

2026-08-18T01:55:08.000Z - 13 days ago

Definium Therapeutics initiated with a Buy at BofA


Definium Therapeutics Announces New Employee Inducement Grants

Aug 17, 2026, 4:01 PM EDT - 13 days ago

Definium Therapeutics Announces New Employee Inducement Grants


Definium Therapeutics Slides: Corporate presentation

Aug 13, 2026, 8:00 AM EDT - 17 days ago

Definium Therapeutics Slides: Corporate presentation


Definium Therapeutics Transcript: Study result

Aug 12, 2026, 8:00 AM EDT - 18 days ago

Definium Therapeutics Transcript: Study result


Definium Therapeutics Press release: Study result

Aug 12, 2026, 8:00 AM EDT - 18 days ago

Definium Therapeutics Press release: Study result


Definium Therapeutics Slides: Study result

Aug 12, 2026, 8:00 AM EDT - 18 days ago

Definium Therapeutics Slides: Study result


Definium Therapeutics Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 24 days ago

Definium Therapeutics Earnings Call Transcript: Q2 2026


Definium Therapeutics Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 24 days ago

Definium Therapeutics Earnings release: Q2 2026


Definium Therapeutics Quarterly report: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 24 days ago

Definium Therapeutics Quarterly report: Q2 2026


Definium Therapeutics reports Q2 EPS ($1.44), consensus (53c)

2026-08-06T20:17:59.000Z - 24 days ago

Definium Therapeutics reports Q2 EPS ($1.44), consensus (53c)


Definium Therapeutics, Inc. Announces Proposed Public Offering

Jun 22, 2026, 4:01 PM EDT - 2 months ago

Definium Therapeutics, Inc. Announces Proposed Public Offering


Definium Therapeutics Transcript: Study result

Jun 22, 2026, 8:00 AM EDT - 2 months ago

Definium Therapeutics Transcript: Study result


Definium Therapeutics Press release: Study result

Jun 22, 2026, 8:00 AM EDT - 2 months ago

Definium Therapeutics Press release: Study result


Definium Therapeutics Slides: Study result

Jun 22, 2026, 8:00 AM EDT - 2 months ago

Definium Therapeutics Slides: Study result


Definium Therapeutics Slides: Corporate presentation

Jun 22, 2026, 7:00 AM EDT - 2 months ago

Definium Therapeutics Slides: Corporate presentation


Definium Therapeutics Transcript: AGM 2026

Jun 11, 2026, 10:00 AM EDT - 2 months ago

Definium Therapeutics Transcript: AGM 2026


Definium Therapeutics Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

Definium Therapeutics Earnings Call Transcript: Q1 2026


Definium Therapeutics Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

Definium Therapeutics Earnings release: Q1 2026


Definium Therapeutics Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

Definium Therapeutics Quarterly report: Q1 2026


Definium Therapeutics Slides: Corporate presentation

May 7, 2026, 4:00 PM EDT - 4 months ago

Definium Therapeutics Slides: Corporate presentation


Definium Therapeutics Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 4 months ago

Definium Therapeutics Proxy statement: Proxy filing


Definium Therapeutics Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 4 months ago

Definium Therapeutics Proxy statement: Proxy filing


Definium Therapeutics Transcript: Investor Day 2026

Apr 22, 2026, 10:00 AM EDT - 4 months ago

Definium Therapeutics Transcript: Investor Day 2026


Definium Therapeutics Slides: FY 2026

Apr 22, 2026, 10:00 AM EDT - 4 months ago

Definium Therapeutics Slides: FY 2026


Psychedelic stocks rally with Trump's support

Apr 20, 2026, 8:26 AM EDT - 4 months ago

Psychedelic stocks rally with Trump's support

ATAI CMPS GHRS


Definium Therapeutics Transcript: Stifel 2026 Virtual CNS Forum

Mar 17, 2026, 3:30 PM EDT - 5 months ago

Definium Therapeutics Transcript: Stifel 2026 Virtual CNS Forum


Definium Therapeutics Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Definium Therapeutics Earnings Call Transcript: Q4 2025


Definium Therapeutics Annual report: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Definium Therapeutics Annual report: Q4 2025


Definium Therapeutics Earnings release: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Definium Therapeutics Earnings release: Q4 2025


Definium Therapeutics Slides: Corporate presentation

Feb 26, 2026, 4:00 PM EST - 6 months ago

Definium Therapeutics Slides: Corporate presentation


Definium Therapeutics Slides: Corporate presentation

Jan 12, 2026, 2:45 PM EST - 8 months ago

Definium Therapeutics Slides: Corporate presentation


MindMed Announces New Employee Inducement Grant

Dec 15, 2025, 4:01 PM EST - 9 months ago

MindMed Announces New Employee Inducement Grant


MindMed Announces New Employee Inducement Grants

Dec 1, 2025, 4:01 PM EST - 9 months ago

MindMed Announces New Employee Inducement Grants


Definium Therapeutics Slides: Corporate Presentation

Nov 9, 2025, 6:00 PM EST - 10 months ago

Definium Therapeutics Slides: Corporate Presentation


Definium Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Definium Therapeutics Earnings Call Transcript: Q3 2025


Definium Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Definium Therapeutics Quarterly report: Q3 2025


Definium Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Definium Therapeutics Earnings release: Q3 2025


MindMed Reports Q3 2025 Financial Results and Business Updates

Nov 6, 2025, 4:01 PM EST - 10 months ago

MindMed Reports Q3 2025 Financial Results and Business Updates


Definium Therapeutics Slides: Corporate Presentation

Nov 6, 2025, 7:00 AM EST - 10 months ago

Definium Therapeutics Slides: Corporate Presentation


MindMed to Participate in Upcoming Investor Conferences

Nov 5, 2025, 7:01 AM EST - 10 months ago

MindMed to Participate in Upcoming Investor Conferences


MindMed to Report Q3 2025 Financial Results on November 6, 2025

Oct 30, 2025, 4:01 PM EDT - 10 months ago

MindMed to Report Q3 2025 Financial Results on November 6, 2025


Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Oct 29, 2025, 4:01 PM EDT - 10 months ago

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering


MindMed to Participate in September Investor Conferences

Aug 28, 2025, 7:00 AM EDT - 1 year ago

MindMed to Participate in September Investor Conferences


Definium Therapeutics Earnings Call Transcript: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 1 year ago

Definium Therapeutics Earnings Call Transcript: Q2 2025


Definium Therapeutics Quarterly report: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 1 year ago

Definium Therapeutics Quarterly report: Q2 2025


Definium Therapeutics Earnings release: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 1 year ago

Definium Therapeutics Earnings release: Q2 2025


Definium Therapeutics Slides: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 1 year ago

Definium Therapeutics Slides: Q2 2025


Definium Therapeutics Transcript: AGM 2025

Jun 12, 2025, 10:00 AM EDT - 1 year ago

Definium Therapeutics Transcript: AGM 2025


MindMed to Participate in June Investor Conferences

May 28, 2025, 7:00 AM EDT - 1 year ago

MindMed to Participate in June Investor Conferences


Suga_shaun
Suga_shaun Aug. 31 at 2:59 AM
0 · Reply
AtomicBanana
AtomicBanana Aug. 29 at 5:47 PM
$DFTX I was waiting at the pharmacy when an adult woman next to me was sobbing on the phone to her senior mother about how the withdrawals for her benzodiazepines were so bad. I could only sympathize with her as she apologized to me for her outburst but I couldn’t blame her one bit Just another reason how important it is that DT120 succeeds. Some people are talking about how Voyage only showed a 14% remission rate. Keep in mind, the trials that benzodiazepines had did not have true remission rates in their studies. The benzodiazepines trials had symptom reduction; not the HAM-A<7 remission endpoint at Week 12 that $DFTX reported I’ve taken both of these drugs before and I can tell you for a fact that I felt nothing but dirty on benzodiazepines and on street LSD I had felt cleansed for months The opportunity ahead is immense. We have an administration in support of these drugs passing. We have a mental crisis that is out of control. A huge drug addiction problem. $DFTX is the cure
1 · Reply
UncleJudd
UncleJudd Aug. 29 at 3:58 PM
$DFTX $CMPS This is tremendous
0 · Reply
Manny559
Manny559 Aug. 29 at 3:26 AM
$DFTX regarding the modest 14% remission in voyage, the only thing that I can point to is that when compared to placebo it’s significantly better than what is currently available
1 · Reply
twiggs462
twiggs462 Aug. 28 at 11:08 PM
Psychedelics Get Federal Attention @TheDalesReport https://www.youtube.com/live/10cdaXsPXcA?si=zh2kyqSlKRYOknXX&t=955 $DFTX $CMPS
1 · Reply
directorwalsh
directorwalsh Aug. 28 at 8:59 PM
$DFTX Remain quite bullish here but any thoughts on only 14% remission in Voyage? Pretty low for my expectations. Understand it’s one dose and remission is a high bar given baseline scores, but even part B seems a bit low.
0 · Reply
Nauticophil
Nauticophil Aug. 28 at 7:43 PM
$DFTX probably related to the uncertain interest rate outlook after Warsh’s Jackson Hole speech. Risk-on assets are down across the board.
0 · Reply
twiggs462
twiggs462 Aug. 28 at 7:12 PM
FDA does not require a drugs to be risk-free. It requires a favorable benefit-risk profile supported by evidence. If $CMPS & $DFTX can demonstrate robust efficacy, safety and workable monitoring, there is nothing disqualifying about psilocybin or LSD being controlled substances.
0 · Reply
AtomicBanana
AtomicBanana Aug. 28 at 6:42 PM
$DFTX Big sell day on no news so no need to ponder or react. We’re chillen
0 · Reply
Horseman23
Horseman23 Aug. 28 at 5:54 PM
$DFTX hope everyone is buying this gift of a dip
0 · Reply
Manny559
Manny559 Aug. 28 at 5:47 PM
$DFTX does anyone know if there is any negative sector news today that’s causing this
2 · Reply
benedicm
benedicm Aug. 28 at 5:07 PM
$DFTX where does this bounce?
2 · Reply
Horseman23
Horseman23 Aug. 28 at 4:38 PM
$DFTX brutal day for the sector
0 · Reply
Rocketzz
Rocketzz Aug. 28 at 4:01 PM
3 · Reply
brunoq14
brunoq14 Aug. 28 at 2:24 PM
$DFTX It generally reverses around 41. Pretty big catalyst coming in September, with an NDA filing for GAD at stake.
0 · Reply
Rocketzz
Rocketzz Aug. 28 at 4:04 AM
2 · Reply
Rocketzz
Rocketzz Aug. 28 at 4:04 AM
$DFTX I miss him
0 · Reply
MichaelNaussCMT
MichaelNaussCMT Aug. 27 at 8:30 PM
$DFTX yes. September
2 · Reply
Hanaleimike
Hanaleimike Aug. 27 at 8:06 PM
$DFTX sideways x 3 months??
1 · Reply
BobbyCucumber
BobbyCucumber Aug. 27 at 4:37 PM
0 · Reply
Suga_shaun
Suga_shaun Aug. 27 at 4:09 PM
$DFTX been holding long and strong since 2020. Curious if anybody else here is invested in TYPTF? Came across the company about a month ago.
1 · Reply
Rocketzz
Rocketzz Aug. 27 at 3:31 PM
1 · Reply